Definition of Emapalumab. Meaning of Emapalumab. Synonyms of Emapalumab

Here you will find one or more explanations in English for the word Emapalumab. Also in the bottom left of the page several parts of wikipedia pages related to the word Emapalumab and, of course, Emapalumab synonyms and on the right images related to the word Emapalumab.

Definition of Emapalumab

No result for Emapalumab. Showing similar results...

Meaning of Emapalumab from wikipedia

- Emapalumab, sold under the brand name Gamifant, is an anti-interferon-gamma (IFNγ) antibody medication used for the treatment of hemophagocytic lymphohistiocytosis...
- IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon gamma 1b Antibodies: Emapalumab Fontolizumab IFNLR (λ, III) See IL-28R (IFNLR) here instead....
- IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon gamma 1b Antibodies: Emapalumab Fontolizumab IFNLR (λ, III) See IL-28R (IFNLR) here instead....
- IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon gamma 1b Antibodies: Emapalumab Fontolizumab IFNLR (λ, III) See IL-28R (IFNLR) here instead....
- IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon gamma 1b Antibodies: Emapalumab Fontolizumab IFNLR (λ, III) See IL-28R (IFNLR) here instead....
- IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon gamma 1b Antibodies: Emapalumab Fontolizumab IFNLR (λ, III) See IL-28R (IFNLR) here instead....
- IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon gamma 1b Antibodies: Emapalumab Fontolizumab IFNLR (λ, III) See IL-28R (IFNLR) here instead....
- IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon gamma 1b Antibodies: Emapalumab Fontolizumab IFNLR (λ, III) See IL-28R (IFNLR) here instead....
- IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon gamma 1b Antibodies: Emapalumab Fontolizumab IFNLR (λ, III) See IL-28R (IFNLR) here instead....
- IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon gamma 1b Antibodies: Emapalumab Fontolizumab IFNLR (λ, III) See IL-28R (IFNLR) here instead....